INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.०२
arrow_upward
+१.५०%(+०.०१५) 1D
अक्टोबर २०, १४:५७:५८ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.०१
High
US$ १.०६
Low
US$ ०.९९
Mkt. cap
१०.४९ करोड
Avg. vol.
२८.४५ लाख
Volume
१८.११ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
Open
US$ १.०१
High
US$ १.०६
Low
US$ ०.९९
Mkt. cap
१०.४९ करोड
Avg. vol.
२८.४५ लाख
Volume
१८.११ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
News stories
From web sources and news partners
Seeking Alpha
·
३० मिनेट पहिले
‘The era of stocks being the only viable investment option has ended’ – Baird Strategas’ (SP500:)
ChartMill
·
५२ मिनेट पहिले
Most Active S&P 500 Stocks in Today's Session
Yahoo Finance
·
१ घण्टा पहिले
Alnylam (ALNY): Can the RNAi Franchise Get it an Entry into the S&P 500 Index?
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc